← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2014Last known activity
Oct 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06077916Lead sponsorN/AOct 1, 2023
- NCT06077916Overall official - principal investigatorN/AOct 1, 2023
- NCT06077916Reponsible party - principal investigatorN/AOct 1, 2023
- NCT03428724Lead sponsorPhase 4Feb 1, 2018
- NCT03428724Reponsible party - principal investigatorPhase 4Feb 1, 2018
- NCT03428724Overall official - principal investigatorPhase 4Feb 1, 2018
- NCT02024022Lead sponsorPhase 4Feb 1, 2014
- NCT02024022Overall official - principal investigatorPhase 4Feb 1, 2014
- NCT02024022Reponsible party - principal investigatorPhase 4Feb 1, 2014
Details
- Last known activity
- Oct 1, 2023